The 29 references in paper S. Demura A., E. Kogan A., V. Paukov S., С. Демура А., Е. Коган А., В. Пауков С. (2015) “Патологическая репарация в зонах ниш стволовых клеток респираторных отделов легкого при идиопатическом легочном фиброзе // Pathologic reparation of the stem cell niche zones of respiratory acini in idiopathic pulmonary fibrosis” / spz:neicon:pulmonology:y:2015:i:3:p:350-356

1
Коган Е.А. Фиброзирующий альвеолит – современные аспекты проблемы. Архив патологии. 1995; 1 (4): 5–11. / Kogan E.A. Idiopathic pulmonary fibrosis: current aspects. Arkhiv patologii. 1995; 1 (4): 5–11 (in Russian).
(check this in PDF content)
2
American Thoracic Society / European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med.2002; 165: 277–304. www.atsjournals.org
(check this in PDF content)
3
Bouros D., Nicholson A.C., Polychronopoulos V., du Bois R.M. Acute interstitial pneumonia.Eur. Respir. J. 2000; 15 (8):
(check this in PDF content)
4
2–418. 4. Nicholson A.G. Classification of idiopathic interstitial pneumonias: making sense of the alphabet soup. Histopathology. 2002; 41: 381–391.
(check this in PDF content)
5
Коган Е.А., Корнев Б.М., Попова Е.Н. и др. Интерстициальные болезни легких: Практическое руководство. М.: Литтерра; 2007. / Kogan E.A., Kornev B.M., Popova E.N. et al. Interstitial lung disease: Practical handbook. Moscow: Litterra; 2007 (in Russian).
(check this in PDF content)
6
Guschall W., Liebertau G., Dittrich I., Schirpke C. Erkrankungsdauer und todesursachen bei patienten mit fibrosierender alveolitis. Lungenfibrose. Atem.-Lungenkrkh. 1998; 24 (3): 10–116.
(check this in PDF content)
7
Johnson M.A., Kwan S. Snell N.J.C. et al. Randomized controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 1989; 44: 280–288. DOI: 10.1136/thx.44.4.280.
(check this in PDF content)
8
Selman M., Ruiz V., Cabrera S. et al. TIMP-1, -2, -3 & -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am. J. Physiol. Lung Cell. Mol. Physiol.2000; 279: 562–574.
(check this in PDF content)
9
Turner-Warwick M., Burrows В., Luburich P. et al. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax. 1980; 35 (4): 593–599.
(check this in PDF content)
10
Selman M. Idiopathic pulmonary fibrosis challenges for the future. Am J. Chest.2001; 120: 8–10.
(check this in PDF content)
11
Bilder D., O'Brien L.E. Beyond the niche: Tissue-level coordination of stem cell dynamics. Ann. Rev. Cell. Dev. Biol.2013; 29: 107–136.
(check this in PDF content)
12
Polak J., ed. Cell Therapy for Lung Disease. London: Imperial College Press; 2010.
(check this in PDF content)
13
Демура С.А., Коган Е.А., Пауков В.С. Морфология и молекулярные основы повреждения ниши стволовых клеток респираторного ацинуса при идиопатических интерстициальных пневмониях.Архив патологии. 2014; 76 (6): 28–36. / Demura S.A., Kogan E.A., Paukov V.S. Morphology and molecular basis of injury of the stem cell niches of respiratory acinus in idiopathic interstitial pneumonias. Arkhiv patologii.2014; 76 (6): 28–36 (in Russian).
(check this in PDF content)
14
Andre C., Hampe A., Lachaume P. et al. (January 1997). Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. Genomics. 1996; 39 (2): 216. DOI: 10.1006/geno.1996.4482. PMID 9027509.
(check this in PDF content)
15
Atlasi Y., Mowla S.J., Ziaee S.A.M. et al. OCT4 Spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. J. Stem Cells.2008; 26 (12): 3002–3267. DOI: 10.1634/stemcells.2008-0530.
(check this in PDF content)
16
Yarden Y., Kuang W.J., Yang-Feng T. et al. Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J.1987; 6 (11): 3341–3351. PMID 2448137.
(check this in PDF content)
17
Schweizer J., Bowden P.E., Coulombe P.A. et al. New consensus nomenclature for mammalian keratins. J. Cell. Biol. Демура С.А. и др. Патологическая репарация в зонах ниш стволовых клеток респираторных отделов легкого 2006; 174 (2): 169–74. DOI: 10.1083/jcb.200603161. PMC 2064177.PMID 16831889.
(check this in PDF content)
18
Suga H., Matsumoto D., Eto H. et al. Functional implications of CD34 expression in human adipose-derived stem / progenitor cells. Stem Cells Dev. 2009; 18 (8): 1201–1210. DOI: 10.1089/scd.2009.0003. PMID: 19226222.
(check this in PDF content)
19
Nakaya Y., Kuroda S., Katagiri Y.T. et al. Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1.J. Dev. Cell. 2004; 7 (3): 425–438.
(check this in PDF content)
20
Aho S., Uitto J. (March). 180-kD bullous pemphigoid antigen / type XVII collagen: tissue-specific expression and molecular interactions with keratin 18. J. Cell. Biochem. 1999; 72 (3): 356–367. DOI: 10.1002/(SICI)1097-4644(19990301) 72:3<356::AID-JCB5>3.0.CO;2-M. PMID 10022517.
(check this in PDF content)
21
Ueda Y., Fujita J., Bandoh S. et al. Expression of cytokeratin 19 mRNA in human lung cancer cell lines. Int. J. Cancer.1999; 81 (6): 939–943.
(check this in PDF content)
22
Zvaifler N.J. Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases. Arthritis Res. Ther. 2006; 8 (3): 210.
(check this in PDF content)
23
Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer.2002; 2: 442–454.
(check this in PDF content)
24
Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol. 2006; 7: 131–142.
(check this in PDF content)
25
Auersperg N., Pan J., Grove B.D et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc. Natl. Acad. Sci. USA. 1999; 96: 6249–6254.
(check this in PDF content)
26
Baum B., Settleman J., Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin. Cell. Dev. Biol.2008; 19 (3): 294–308.
(check this in PDF content)
27
Davies J.A. Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta. Anat. 1996; 156 (3): 187–201.
(check this in PDF content)
28
Herbst R.S. Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol. Biol. Phys.2004; 59 (Suppl. 2): 21–26. DOI: 10.1016/j.ijrobp.2003.11.041.PMID 15142631.
(check this in PDF content)
29
Коган Е. А., Тыонг Ф.В., Демура С.А. Молекулярные основы формирования вариантов идиопатического фиброзирующего альвеолита. Архив патологии. 2009; 71 (1): 12–18. / Kogan E. A., Tyong F.V., Demura S.A. Molecular basis of different patterns of idiopathic pul-
(check this in PDF content)